Apixaban is a novel oral anticoagulant.

Chengdu Baiyu Pharmaceuticals Co., Ltd. was established in 2005 with a registered capital of nearly 16 million dollars. With innovative drugs as the core, focusing on chemical drugs, biological drugs and botanical drugs especially Glikgolide injection. Baiyu has grown into an integrated enterprise engaging in R&D, production, sales, and cultivation of Traditional Chinese Medicine. Baiyu group has eight wholly-owned subsidiaries with more than 1400 employees including its own 260 R&D members, whose business covers preparations, APIs, medical masks and other related fields.

Address: No.343 Hezuo Road, West Hi-Tech Zone, 611731, Chengdu, Sichuan, China.

Tel: +86-28 83379750, ext 8011